Investigators are researching the impact of Microbiota Transfer Therapy on Autism and gastrointestinal symptoms in patients with Autism. A phase 1 clinical trial found Autism symptoms reduced nearly 50% two years after microbiota therapy. Read more about the initial trial.
Additional information about the Autism Research Program at Arizona State University is available here.
ASU Researchers Dr. James Adams& Dr. Rosa Krajmalnik-Brown share results from their research.
Hear from patients enrolled in the trial and here.
A Phase 2, double-blind, placebo-controlled study is underway at Arizona State University utilizing Microbiota Transplant Therapy with pediatric and adult patients. More information regarding the current trial is available here.